Learn how pulmonary hypertension specialists develop personalized treatment plans for patients. Christopher King provides an overview of the four treatment pathways and the role of early combination therapies to treat pulmonary hypertension. He explains how factors like your PH type and severity, medical history, personal preferences, and regular follow-up visits that monitor disease and determine risk stratification help guide decisions throughout your long-term care plan.

Speaker

Christopher King, MD, FCCP
Associate Medical Director, Advanced Lung Disease and Transplant Program
PFF Center Director
Associate Medical Director, PAH and CTEPH Program
System Director, Respiratory Care Services